A detailed history of Concourse Financial Group Securities, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 233 shares of SRPT stock, worth $28,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares
233
Previous 241 3.32%
Holding current value
$28,912
Previous $38,000 23.68%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$124.33 - $156.75 $994 - $1,254
-8 Reduced 3.32%
233 $29,000
Q2 2024

Jul 23, 2024

BUY
$113.33 - $163.85 $1,359 - $1,966
12 Added 5.24%
241 $38,000
Q1 2024

Apr 30, 2024

BUY
$93.7 - $141.53 $562 - $849
6 Added 2.69%
229 $29,000
Q3 2023

Oct 25, 2023

BUY
$102.5 - $123.59 $16,092 - $19,403
157 Added 237.88%
223 $27,000
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $7,756 - $10,295
66 New
66 $9,000
Q4 2022

Jan 30, 2023

SELL
$100.86 - $132.13 $6,656 - $8,720
-66 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$63.15 - $90.42 $93,209 - $133,459
-1,476 Reduced 95.72%
66 $5,000
Q4 2021

Feb 07, 2022

SELL
$77.28 - $99.42 $7,728 - $9,942
-100 Reduced 6.09%
1,542 $139,000
Q3 2021

Nov 09, 2021

SELL
$65.97 - $92.48 $3,958 - $5,548
-60 Reduced 3.53%
1,642 $152,000
Q2 2021

Aug 13, 2021

BUY
$69.38 - $86.75 $4,162 - $5,205
60 Added 3.65%
1,702 $132,000
Q1 2021

May 13, 2021

SELL
$72.25 - $168.95 $3,973 - $9,292
-55 Reduced 3.24%
1,642 $122,000
Q4 2020

Feb 02, 2021

BUY
$125.56 - $178.74 $1,004 - $1,429
8 Added 0.47%
1,697 $289,000
Q3 2020

Nov 13, 2020

BUY
$127.12 - $172.34 $31,398 - $42,567
247 Added 17.13%
1,689 $237,000
Q1 2020

May 13, 2020

BUY
$82.38 - $131.64 $65,904 - $105,311
800 Added 124.61%
1,442 $141,000
Q3 2019

Nov 13, 2019

SELL
$72.81 - $156.91 $2,257 - $4,864
-31 Reduced 4.61%
642 $48,000
Q2 2019

Aug 13, 2019

BUY
$112.21 - $151.95 $62,052 - $84,028
553 Added 460.83%
673 $102,000
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $12,800 - $18,201
120 New
120 $14,000
Q4 2018

Feb 14, 2019

BUY
$97.32 - $148.76 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018

BUY
$115.31 - $161.51 $0 - $0
0 New
0 $0

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.